GENEVA, Oct. 6 -- ATAI THERAPEUTICS, INC. (c/o Industrious NYC250 West 34 StNew York, New York 10119), RAO, Srinivas G. (c/o Atai Therapeutics, Inc.Industrious NYC250 West 34th StNew York, New York 10119), BUSBY, Robert (c/o Atai Therapeutics, Inc.Industrious NYC250 West 34th StNew York, New York 10119), MILZ, Ruth (c/o Atai Therapeutics, Inc.Industrious NYC250 West 34th StNew York, New York 10119), CRAIG, Kevin (c/o Atai Therapeutics, Inc.Industrious NYC250 West 34th StNew York, New York 10119) filed a patent application (PCT/US2025/021344) for "INTRAVENOUS ADMINISTRATION OF IBOGAINE FOR TREATING OPIOID USE DISORDER" on Mar 25, 2025. With publication no. WO/2025/207633, the details related to the patent application was published on Oct 02,...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.